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Abstract: This paper reviews a number of biomedical engineering approaches to help aid 
in the detection and treatment of tropical diseases such as dengue, malaria, cholera, 
schistosomiasis, lymphatic filariasis, ebola, leprosy, leishmaniasis, and American 
trypanosomiasis (Chagas). Many different forms of non-invasive approaches such as 
ultrasound, echocardiography and electrocardiography, bioelectrical impedance, optical 
detection, simplified and rapid serological tests such as lab-on-chip and micro-/nano-fluidic 
platforms and medical support systems such as artificial intelligence clinical support 
systems are discussed. The paper also reviewed the novel clinical diagnosis and 
management systems using artificial intelligence and bioelectrical impedance techniques 
for dengue clinical applications. 
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1. Introduction 
The original designation of certain diseases as being tropical can be dated back to the 1898 
publication of Sir Patrick Mansonʼs Tropical Diseases: A Manual of the Diseases of Warm Climates [1]. 
Tropical diseases (TD) are diseases that are widespread in or unique to the tropical and subtropical 
regions. TDs are prevalent in hot and humid climates. TDs are caused by pathogenic agents such as 
bacteria, viruses, parasites or fungi and are most often transmitted through carriers or vectors such as 
insects and nematodes. These insects may carry a parasite, bacterium or virus that is transmitted via 
their bite which disperses the infectious agent by subcutaneous blood or saliva exchange in humans 
and animals. Examples of tropical diseases include malaria, tetanus, hepatitis, American 
trypanosomiasis (chagas), dengue, yellow fever, cholera, nipah virus, and many others. We will look at 
some of these where biomedical engineering approaches have contributed to their diagnosis and treatment. 
Rapid, efficient and inexpensive diagnosis of TDs is vital for the effective treatment and quality 
management of diseases in tropical regions. Diagnosis of TDs consists of a wide range of methods 
including serological testing of pathogenic markers such as protein, antigen, and antibody (using the 
enzyme-linked immunosorbent assay (ELISA) technique and various test kits), x-rays and physical 
examination, as well as performing bacteria and fungi culture techniques. These methods typically 
require a sample of bodily fluid, such as blood, sputum, or urine and/or stool samples. However, the 
management and diagnosis of TDs face several challenges such as prolonged turnaround time for 
assessment of specimens, high cost, a controlled environment, highly trained personnel, and large 
blood or bodily fluid samples. Associated measurements are often invasive, and in order to be useful, 
diagnostic methods must be accurate, simple and affordable for the population for which they are 
intended. They must also provide a result in time to institute effective treatment and patient isolation 
when necessary. Current diagnostic methods for TDs are frequently faced with challenges such as 
inconsistency in specificity and sensitivity, a long turnaround time to receive results, and high cost or 
specialization (which requires either an advanced and expensive laboratory setup, or skilled 
technicians and clinicians, or both). 
Recent research and studies in the past decade have proposed and introduced various biomedical 
engineering approaches that attempt to address the issues faced in the diagnosis of tropical diseases.  
This review paper focuses on current biomedical engineering approaches for the more prominent 
diseases of dengue, malaria, cholera, schistosomiasis, lymphatic filariasis, ebola, leprosy, 
leishmaniasis, and American trypanosomiasis (chagas). Many of these approaches can be extended to 
other diseases as well. 
These diseases were chosen as examples due to their severity and endemic nature and the perceived 
limitations of the current diagnostic methodology. In recent years outbreaks of dengue have been 
escalating and spreading geographically throughout the world with high mortality rates when timely 
treatment is not administered [2,3]. The number of infections of malaria and schistosomiasis is in the 
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range of hundreds of millions, with the annual mortality rates in the range of hundreds of  
thousands [4,5]. From 2009 to 2010, the number of cases and deaths due to cholera has increased by 
about 50% [6], while sporadic outbreaks of ebola have been noted to be extremely deadly, killing the 
patient within 2 days after acquiring the infection [7]. The disease of lymphatic filariasisis is wide 
spread, infecting 120 million people and disfiguring 40 million worldwide [8], while leprosy has an 
annual infection rate of 200,000 a year, and causes permanent damage to the skin, nerves, limbs and eyes 
if untreated [9]. Around the world, millions of people are infected with leishmaniasis and American 
trypanosomiasis (chagas), and millions more are at risk due to the endemic nature of these  
diseases [10–12]. 
Although the diseases are different, many of the biomedical engineering approaches are common 
for their diagnosis and treatment. Table 1 presents the relation between the diseases and biomedical 
engineering approaches for their Diagnosis and Treatment. In the following sections we review 
biomedical engineering approaches that are currently available for diagnosis and establishing 
prognosis of the tropical diseases listed in Table 1. As seen in the table, a wider variety of biomedical 
engineering approaches have been applied to diseases such as dengue and malaria than some of the 
diseases on the right side of the table. 
Table 1. Relation between the Tropical Diseases and their Diagnosis and Treatment via 
Biomedical Engineering approaches.  
Biomedical Engineering Approach to 
Diagnosis and Treatment 
Tropical Diseases 
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Bioelectric Impedance Analysis X  X X      
Bioelectric Properties  X        
Biosensor      X  X X 
Clinical Decision Support Systems X         
Dielectrophoresis  X        
Echocardiography X         
Electrocardiography X         
Image Processing  X        
Imaging: Computed Tomography (CT) and 
Magnetic Resonance Imaging (MRI) 
   X X  X   
Imaging: Ultrasonic X   X X  X   
Laser Doppler Velocimetry X         
Microarray chip  X        
Microfluidics and Lab-on-a-Chip X X X       
Paper-based Diagnostic X X        
Plethysmography X         
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2. Dengue 
One of the most rapidly spreading mosquito-borne viral diseases in the world is dengue.  
The incidence of dengue has increased in the last 50 years as a result of increasing geographic 
expansion to new countries and to rural areas [2]. Annually, the World Health Organization (WHO) 
estimates the occurrence of 50 million dengue infections occurring and approximately 2.5 billion 
people facing threats of dengue since they live in dengue endemic areas [13]. 
According to the WHO 1997 guidebook of Dengue Haemorrhagic Fever: Diagnosis, Treatment, 
Prevention and Control, 2nd ed. [13], some patients develop dengue fever (DF) in the early stage after 
a person is infected with the dengue virus and recover after the fever subsides, while other patients 
may progress on to develop dengue haemorrhagic fever (DHF). 
Laboratory and clinical diagnosis are used to diagnose the dengue patient. The clinical diagnosis 
and severity of DHF were graded from grades I to IV based on the WHO guidebook recommendation 
in 1997 [13]. The WHO guidelines define Grade I as patients having a fever accompanied by 
nonspecific constitutional symptoms with the only haemorrhagic manifestation being a petechial rash. 
Grade II is defined as patients having a spontaneous bleeding from any site on their skin. Grades III 
and IV are known as dengue shock syndrome (DSS). Grade III is where a patient has circulatory 
failure manifested by rapid and weak pulse, narrowing of pulse pressure (20 mmHg or less) or 
hypotension, with the presence of cold clammy skin and restlessness. Grade IV (DSS) is defined as 
patients having profound shock [13]. 
With the WHO 1997 dengue severity classification guideline [13], many clinicians experienced 
several difficulties especially in the critical cases such as the DHF patients which may experience 
significant plasma leakage that may lead to haemorrhage and organ impairment. The decision to admit 
those patients to the hospital in order to monitor their plasma leakage is a great challenge due to the 
overlapping of present medical classification criteria for establishing the risk of dengue patients [14,15]. 
On the other hand, physicians cannot decide to admit all patients because this will have an impact on 
the cost and quality of health care due to the high incidence of dengue in the tropics. Thus, to 
overcome these difficulties and to assist clinicians in determining the severity of the infection and how 
patients should be treated, the WHO has improved and introduced the new [2] guidebook which 
defines the dengue patients’ classification according to a few levels of severity. This guideline has 
been approved in year 2010 and valid until year 2014. In this new guidebook, the dengue patients are 
no longer classified as DF and DHF, instead patients are divided into two simplified groups. They are 
either severe or non-severe dengue patients. The non-severe dengue patients are further classified into 
two subgroups: patients with warning signs and those without warning signs. 
In the new WHO 2009 guidebook [2], the classification criteria for non-severe dengue without 
warning signs are fever and any two of the following: nausea/vomiting, rash, aches and pain, a positive 
tourniquet test, leucopoenia, and there may even be a combination of these warning signs. The warning 
signs for non-severe dengue with warning signs are: abdominal pain or tenderness, persistent vomiting, 
clinical fluid accumulation (pleural effusion/ascites), mucosal bleeding, lethargy, restlessness, liver 
enlargement (>2 cm), and an increase in hematocrit (HCT) concurrent with a rapid decrease in platelet 
count. Such patients with these warning signs require strict observation and medical intervention. 
Severe dengue infections are characterized by significant plasma leakage, severe bleeding, and severe 
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involvement of organs such as the liver. This causes liver enzymes such as aspartate aminotransferase 
(AST), or the alanine aminotransferase (ALT) to be elevated with readings of ≥1000 units/L. 
Laboratory diagnosis of dengue patients is used to detect the dengue virus. Currently, a definitive 
diagnosis of dengue infection can be made only in the laboratory, either through virus isolation, 
detection of viral antigen or ribonucleic acid (RNA) present in serum or other bodily fluid, detection of 
antibodies present in serum, or a combination of these techniques [2,16]. At the early stage of 
infection, virus isolation and the detection of nucleic acid or antigen is used to make a diagnosis of 
dengue infection; however at the end of the acute phase of infection serological methods are more 
suitable [2]. A number of commercially rapid test kits (or coated strips) have been developed by 
various companies such as Korea’s Standard Diagnostics, Biorad and Panbio. These kits are able to 
detect a combination of either antigen or antibodies [3]. 
Although rapid laboratory diagnosis is very important and highly desirable, of equal importance is 
the recovery rate of the patient and the patient’s quality of life after recovery. To date, there is no 
effective vaccine or antiviral drug for dengue [2]. Some of the dengue patients might recover 
spontaneously while others face critical plasma loss that can lead to fatality [13]. Serology tests are not 
able to diagnose the micro-vascular status (micro-vascular leakage or plasma leakage) of the patient 
which is one of the major pathophysiological changes during dengue infection. Nevertheless the 
fatality of dengue disease can be reduced by close monitoring of patients to detect the onset of plasma 
leakage and administer prompt intravenous fluid replacement [17]. 
2.1. Biomedical Engineering Approaches 
In order to overcome some of the difficulties in conventional dengue infection diagnostic methods, 
a few biomedical engineering (BME) approaches were introduced by proposing non-invasive tools to 
diagnose and classify the disease severity. These included techniques such as ultrasound imaging, 
echocardiography, electrocardiography, plethysmography, laser Doppler velocimetry, bioelectrical 
impedance, and intelligent clinical decision support systems. However, many of these papers reviewed 
in the following sections were based on the WHO 1997 [13] dengue classification as the new WHO 
2009 [2] classification was introduced in the year of 2010, after these papers have been published. 
2.1.1. Ultrasound 
The critical stage in dengue occurs when the capillary permeability increases which leads to plasma 
leakage and therefore loss of plasma volume. The presence of pleural effusion and ascites are often 
used to determine the degree of plasma leakage. These are clinically detectable through physical 
examination techniques such as auscultatory percussion, and imaging techniques such as chest 
radiography, and also abdominal and thoracic ultrasonic imaging. Accordingly, several studies have 
used ultrasound as an aid for diagnosing dengue disease [18–20]. 
In the study by Srikiatkhachorn et al. [18] ultrasound has been employed to delineate the locations 
and the timing of plasma leakage in DHF. In the study, one hundred fifty-eight suspected dengue cases 
classified as DF, DHF, or other Febrile Illness (OFI) based on serology and evidence of plasma 
leakage including hemoconcentration and pleural effusion, were investigated. Ultrasound examinations 
of the abdomen and right thorax of patients were performed to detect ascites, thickened gall bladder 
Sensors 2015, 15 6952 
 
 
wall, and pleural effusions. The results indicated that the timing of the plasma leakage was around the 
time of defervescence. The Pleural effusion was the most common ultrasonographic sign of plasma 
leakage while the thickening of the gallbladder wall and ascites were not associated as much in 
determining the plasma leakage. Significantly, plasma leakage of 12 out of 17 DHF cases who did not 
meet the WHO criteria for hemoconcentration signs was detected by ultrasound. The study concluded 
that ultrasound imaging is a useful tool for detecting plasma leakage in dengue infection. 
Another study by Venkata et al. [19] was conducted to determine the importance of the ultrasound  
to clinical and laboratory profiles in diagnosing DF or DHF and to determine the usefulness of  
ultrasound in predicting the severity of the disease. One hundred twenty-eight suspected dengue 
patients (40 serologically negative for dengue fever and 88 serologically positive cases) were studied. 
Results of 32 patients from the 88 cases who were examined on the second to third day and repeated 
on fifth to seventh day showed that 100% had gall bladder wall thickening and pericholecystic fluid. 
Follow-up ultrasound on the fifth to seventh day showed ascites in 53%, left pleural effusion in 22%, 
and pericardial effusion in 28%. The results of the remaining 56 patients who were examined on the 
fifth to seventh day of fever for the first time showed that 100% had gall bladder wall thickening, 96% 
had ascites, 87.5% had right pleural effusion, and 66% had left pleural effusion. Contrary to the 
previous study, this study reported that thickened gall bladder wall, pleural effusion, and ascites should 
strongly favour the diagnosis of dengue fever. 
In a separate work by Setiawan et al. [20], a study was conducted to examine the relationship 
between the clinical severity of 148 DHF patients (73 grades I and II; 75 grades III and IV) and their 
sonographic findings. Ultrasonography results revealed that the main features presented with grades I 
and II DHF patients were hepatomegaly 49%, ascites 34%, gallbladder wall thickening 32%, and 
pleural effusions 30%. On the other hand, the main features detected in DHF patients grades III and IV 
groups were pleural effusions, ascites and gallbladder wall thickening 95%, pararenal and perirenal 
fluid collections 77%, hepatomegaly 56%, and pancreatic gland enlargement 44%. The study 
concluded that ultrasound may be useful for early prediction of the severity of DHF. 
2.1.2. Echocardiography and Electrocardiography (ECG) 
Echocardiography and electrocardiography (ECG) were utilized in several studies to assess cardiac 
function of dengue patients [21–23]. 
Acute shock in severe DHF cases may occur in parallel with accumulation of fluid in serous body 
spaces such as the pleural, peritoneal, and pericardial cavities [21]. Pelupessy et al. [21] investigated 
the implementation of echocardiography in diagnosing dengue patients since echocardiography is a 
very sensitive method for detecting any small quantity of pericardial effusion The study showed that, 
although no signs of pericardial effusion could be determined on physical examination of DHF patients 
associated with severe shock and through ECG and radiological procedures, echocardiogram results 
were able to clearly show a small amount of fluid. Thus this technique is only recommended for the 
application of acute shock dengue patients. 
In 1998, Wali et al. [22] employed radionuclide ventriculography, echocardiography, and ECG to 
assess cardiac function of 17 DHF and DSS patients. The radionuclide ventriculography results 
revealed that, the mean left-ventricular ejection fraction was 41.69%. Seven patients had an ejection 
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fraction of less than 40%. Global hypokinesia was detected in 70.59% of the patients. The 
echocardiography results showed that the mean ejection fraction was 47.06%. The mean ejection 
fraction of the 8 DSS patients was 39.63%. Five (67.5%) of those patients had an ejection fraction 
below 40%. Radionuclide ventriculography and echocardiography showed no abnormalities after  
3 weeks of follow up for five patients who had ST and T changes in their electrocardiogram.  
The ejection fraction was more than 50% in these cases. Within 3 weeks, the Global hypokinesia also 
improved and ECG changes reverted back to normal. The study concluded that acute reversible cardiac 
insult may be noticed in DHF/DSS and could be responsible for hypotension/shock seen in some of 
these patients. It was recommended that further studies are carried out to establish the pathogenic 
mechanisms of cardiac dysfunction in patients with DHF and DSS. 
In 1993, Yusoff et al. [23] performed echocardiograms and ECGs on 28 consecutive adult patients 
with a clinical diagnosis of dengue infection. Twenty-three dengue patients were serologically 
confirmed (22 DHF grades I and II; 1 DF). 87% of the serologically confirmed dengue patients had 
abnormal ECGs and/or echocardiograms. Of these, 65% had abnormal ECGs that consisted of 
conduction abnormalities, ST segment elevation, T wave inversion, and sinus bradycardia. Fifty-two 
percent had abnormal echocardiograms which showed pericardial effusion, abnormal systolic and 
diastolic functions, left ventricular dilatation, and tricuspid regurgitation. The authors declared that 
ECG and echocardiographic abnormalities are common during the acute phase of DHF. They 
recommended early detection of cardiac involvement as a way of identifying the more severe forms of 
dengue so that appropriate treatment can be initiated as early as possible. 
2.1.3. Strain Gauge Plethysmography 
Liquid metal (Mercury-in-silicon elastomer tube) strain gauge plethysmography has been used in 
various studies to assess the microvascular permeability in dengue patients [24,25]. Gamble et al. [24] 
investigated the possible use of age-related changes in microvascular permeability as a health 
indicator, and it was found that the value was highest in DSS young children. These findings indicated 
that children significant factor in the susceptibility of children to DSS using strain gauge 
plethysmography [24]. Both adults and children DSS patients were found to have higher vascular 
permeability than the healthy control data, and the value was highest in the young children. These 
findings indicated that children are more susceptible to develop hypovolaemic shock than adults in 
DHF and other conditions characterized by increased microvascular permeability. 
Bethell et al. [25], on the other hand, investigated whether the underlying pathophysiology of DSS 
is distinct from the milder forms of the disease by assessing the microvascular permeability also using 
strain gauge plethysmography. Three groups were investigated: children with DSS, DHF without 
shock, and in healthy children. The mean coefficient based on the statistical analysis of microvascular 
permeability for the patients with dengue was 50% higher than in healthy control patients. However, 
there was no significant difference in the permeability between the two groups of patients with dengue, 
which suggests the same underlying pathophysiology. This study also demonstrated that increased 
microvascular leakage occurs in children with DHF, and is most pronounced in children with DSS. 
However, the time taken to conduct the measurement was long (40 min average), and the procedure of 
cuffing the patients may put the patients at risk by inducing more capillary leakage. 
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2.1.4. Laser Doppler Velocimetry 
Laser Doppler velocimetry has been widely used for assessment of various physiological 
parameters, particularly involving blood perfusion and circulation [26–29]. The technique has also 
been recently applied to DHF patients to evaluate the microcirculation changes due to plasma leakage 
and increase of microvascular permeability [30]. The preliminary findings of this study indicated that 
there were significant differences between basal laser Doppler flux in normal healthy subjects and 
DHF patients. These results also implied that the technique has the potential as an indicator to 
microcirculatory changes in DHF patients. The study has not; however been able to conclusively 
differentiate the DHF severity stages using this technique. 
2.1.5. Bioelectrical Impedance 
Over the years, bioelectrical impedance analysis (BIA) has demonstrated its utility as a non-invasive 
method for measurement and diagnosis in several medical applications. BIA evaluates the human body 
composition such as mass distribution (i.e., body cell mass and extracellular mass), and water 
compartments (i.e., intracellular water, extracellular water) by passing a small current through  
it [31]. The majority of the impedance measurements use four electrodes to minimize electrode-skin 
impedance effects. A small high-frequency current (50 kHz) is passed between two of the electrodes 
while the voltage drop across the same area is then measured using the other pair of electrodes. The 
ratio of the voltage drop to the current determines the resistance and reactance (Xc) of the body 
segment being measured. This data can then estimate the extracellular water (ECW), intracellular 
water (ICW), fat free mass (FFM), and fat mass through recognized equations [32]. 
BIA and bioelectrical impedance spectroscopy (BIS) have been described as a potentially reliable 
method to assess clinically significant changes in extracellular and total body water in dengue  
patients [33–37]. It could be a useful tool as a proxy for formal dilution methods to assess fluid shifts. 
Pierson and Wang (1986) have also proposed that an elevation of the extracellular water 
(ECW)/intracellular water (ICW) ratio in dengue patients, determined by dilution techniques, is a 
sensitive but nonspecific marker for the presence of systemic disease, and total body impedance 
measurements are especially useful in this determination. 
In dengue infections several approaches were followed for utilizing the BIA technique.  
The hydrational profile which reflects the distribution of body water between the intra and 
extracellular space in dengue patients was investigated [38–44]. 
Studies conducted by Klassen et al. [42], Ibrahim et al. [38], and Mazariegos et al. [44] have shown 
that BIA was sensitive in determining the hydrational profile in dengue patients. Klassen et al. [42] 
studied the changes in hydrational status during the acute phase of classical dengue fever in 9 adult 
patients. They studied the effects of the acute classical dengue fever on ECW, ICW, and total body 
water (TBW) by comparing conventional dilution techniques with the outcome variables from whole 
body impedance spectroscopy (BIS), extracellular fluid resistance (Recf), and intracellular fluid 
resistance (Ricf) [42]. Two groups were investigated: a reference group comprised of 15 subjects 
without acute or chronic illness and dengue patients. The dengue patients were investigated on 
admission with febrile presentation (DI), at discharge after the defervescence of the fever cycle at 
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about five days post-admission (DII), and seven days thereafter (DIII). The results revealed that the 
total body water did not change during the course of the disease and was not different from that in 
normal healthy subjects. However, the ratios of ECW/TBW and ECW/ICW reflected that body water 
shifted from the intracellular to the extracellular compartment in patients from the acute phase to 
convalescence. This ratio was also higher in convalescent dengue patients (DIII) compared to the 
reference group. The results also showed an association between increasing ECW, from the acute 
phase of the disease to convalescence and decreasing the Recf and the Recf/Ricf ratio. Moreover, the Recf 
and Recf/Ricf values were higher in the acute phase (DI) of dengue fever compared to those of the  
non-dengue subjects. The study concluded that relative expansion of ECW during the course of the 
disease and in the convalescence stage as determined by measuring body impedance can be used to 
monitor the dengue fever progression. 
Fang et al. [45] reported a biosensor platform for dengue fever detection from patient serum. Their 
sensor was based on a non-faradic process where an integrated sensor captures the dengue antibody 
selectively from the sample. A thin film of sol-gel derived barium strontium titanate (BST) was coated 
on the immunosensor surface, and then the surface was modified with an organic self-assembled 
monolayer (SAM). In addition, pre-inactivated dengue virus was indirectly immobilized on the surface 
to act as a sensing probe to capture the dengue antibody. Finally, the modified surface was based on a 
finger shaped electrode where the output impedance/current will change in correlation with the 
presence and concentrations of dengue antibody in the serum sample. The work was conducted at 
frequency ranges of 0.1 Hz to 1 MHz. 
Ibrahim et al. [46] monitored and modelled the hemoglobin (Hb) status in dengue patients using the 
BIA parameters. The Hb status was used since it is directly related to the Hct status which can be used 
to determine the degree of microvascular permeability in dengue patients. The BIA was employed to 
construct a model for predicting Hb in dengue patients using the multivariate analysis technique.  
Eighty-three (47 males and 36 females) serologically confirmed DF and DHF patients were studied 
during their hospitalization. The data consisted of all the investigated parameters in BIA, patientsʼ 
symptoms, and demographic data. Four predictors: reactance, gender, weight, and vomiting were 
found to be the most significant parameters for predicting the Hb levels in dengue patients. The study 
concluded that the single frequency bio-impedance technique and Multiple-linear-regression analysis 
is insufficient to monitor Hb for dengue patients since this analysis only explains approximately 42% 
of the Hb variation. This model has been enhanced by utilizing a non-linear artificial neural network 
(ANN) and achieved 74% accuracy [47]. The graphical user interface for the model is shown in Figure 1. 
The enhanced model is able to predict the Hb concentration which helps to determine the degree of 
microvascular permeability in dengue patients based on the above mentioned data. 
Additional enhancement of the model was achieved by employing the nonlinear autoregressive 
moving average with exogenous input (NARMAX) approach [48]. Three different NARMAX model 
order selection criteria, namely FPE, AIC, and Lipschitz were evaluated. The results gave 88.40% 
prediction accuracy by using the Lipschitz number approach. The study concluded that the NARMAX 
model yields better accuracy compared to the autoregressive moving average with exogenous input 
(ARMAX) model which achieved 76.70% accuracy.  
  
Sensors 2015, 15 6956 
 
 
 
Figure 1. Non-invasive haemoglobin modelling of dengue patients using bioelectric 
impedance analysis and artificial neural networks. 
2.1.6. Dengue Clinical Decision Support Systems 
A physician’s knowledge would be sufficient to diagnose diseases that are directly related or 
corroborate to the encyclopaedic aspects of medicine. However, the complexity of diseases such as 
dengue and the many overlapping levels of its severity has created many difficulties for the physician 
to predict the disease prognosis. Accordingly, there is a crucial need for a decision support system to 
assist the health care provider in understanding the disease and to plan for its treatment. This is 
especially true when providers with less training than a physician are caring for patients, a factor 
crucially important in the developing world. In dengue, several approaches have been followed to 
achieve this goal including the self-organized map, multilayer feed-forward neural networks 
(MLFFNN), and adaptive neuro-fuzzy inference system (ANFIS) techniques. 
Self-Organizing Map (SOM) 
The self-organizing map (SOM) is an unsupervised neural network that is considered as one of the 
most powerful aids for visualizing, analyzing, and understanding the complexity of high-dimensional 
data. It receives a number of different multivariable input samples, discovers significant relationships 
in these samples, and presents them into a two dimensional map. This map contains different data 
clusters (prototypes), each of them consisting of samples that have similar features. Similarly, 
relationships within the data and cluster structures can be visualized and interpreted. Therefore, the 
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SOM can be considered as an exploratory data analysis tool for generating hypotheses on the 
relationships among the data. The SOM has been widely used in medical applications [49–53]. Typical 
SOM can be visualized by using the U-matrix and the component planes. The U-matrix visualizes the 
distances between map units which is used to show the cluster structure of the map. Normally it is 
colored and these colors represent the distance between map units [54]. Colors with high values in the  
U-matrix indicate a cluster border while colors with low value indicate the clusters themselves. The 
value of the color is presented in the color scale beside the U-matrix. On the other hand, the 
component planes present values of all variable in each U-matrix map unit. 
In dengue infections, the SOM was employed to identify the non-invasive significant prognosis 
factors that can distinguish between dengue patients and healthy subjects and also distinguish between 
the male and female patients [47]. The study presented a new approach to determine the significant 
prognosis factors in dengue patients utilizing the SOM. This technique showed the significant factors 
that can differentiate between dengue patients and the healthy subjects. Three hundred twenty-nine 
samples (210 dengue patients and 119 healthy subjects) were used in the study. Each sample contained 
35 predictors (17 BIA parameters, 18 symptoms/signs). Two SOMs were constructed as shown in  
Figure 2. Each map contains the U-matrix (on the top left of the map) and the component planes that 
represent the value of the variable in the U-matrix. The bottom left of each map shows the labels 
which indicate the type of patient in each cluster of the U-matrix map (healthy subject (H) or dengue  
patients (D)).The first map was constructed based on the BIA parameters data (variables) while the 
second map utilized the symptoms and signs data (variables). By visualizing the U-matrix and 
investigating the similarity between the clusters in the U-matrix and the component planes, the 
correlations between the dengue patients and the prognosis factors form the symptoms and signs and 
BIA parameters can be defined. The results revealed that, the significant BIA prognosis factors for 
differentiating the dengue patients from the healthy subjects were reactance, ICW, ratio of ECW/ICW, 
and ratio of the extracellular mass to body cell mass. On the other hand, abdominal epigastic pain, 
petechiea rash, and bleeding tendency were the main signs and symptoms that were present in  
dengue patients. 
Due to the limitations of the WHO 1997 classification criteria that have been used to classify the 
severity of dengue patients, Faisal et al. [55] employed clustering, the SOM’s technique to determine 
new criteria that may help classify dengue patients based on disease severity. This technique aims to 
apply the K-mean clustering technique to cluster the SOMʼs prototypes rather than clustering the data 
directly to enhance the data clustering. Generally, the implementation of this approach is performed in 
two stages: First, the SOM is trained to identify the prototypes of the dengue patients’ data, and 
second, the K-mean clustering technique is implemented to cluster those prototypes. As a result, three 
criteria were then defined to classify the level of risk in dengue patients. The results were validated by 
comparing them to some other dengue researchers’ findings as well as the WHO criteria [2,13]. By 
using this technique, important results were obtained: the new risk criteria classified 33% of the DF 
patients as high risk dengue patients. Those patients might not be hospitalized according to the WHO 
criteria since they were classified as DF patients. However, those patients were classified as high risk 
by using the new criteria and thereby they might be at risk and face death if they are not closely 
monitored to detect the onset of plasma leakage. Another significant result was that 65.5% and 57.7% 
of the patients who were classified by WHO as DHF I and DHF II, respectively, were classified by the 
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new criteria as low risk dengue patients. Those patients need not be hospitalized since they are classified 
as low risk patients and therefore the savings on the cost of the hospital admissions can be substantial. 
This result agrees with other researchers’ findings [14] and the recent WHO guidelines which indicates 
there is a problem using the existing WHO classification due to the changes in the epidemiology of 
dengue, and there is a high potential for the clinicians’ decision to be based the levels of severity for 
classifying the patients [2]. 
(a) 
(b) 
Figure 2. (a) Visualization of the self organizing maps for the bioelectric impedance 
analysis parameters; (b) Symptoms, and signs data. Reproduced with permission [47]. 
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Multilayer Feed-Forward Neural Networks (MLFFNN) 
ANNs have been successfully applied to several problems in dengue disease. Ibrahim et al. [56] 
employed the multi-layer perceptron (MLP) network trained via the back-propagation (BP) algorithm 
to develop a prediction system for predicting the day of fever reduction in dengue patients due to the 
fact that the progression of the DHF patient to DSS occurs following this day. Ninety percent 
prediction accuracy was achieved by using this approach. The study concluded that since most of the 
dengue patients were sick during or around the time of fever reduction, this ANN might be very 
promising to assist clinicians in the early determination of prognosis and in prescribing the 
management plan for their patients. 
The network architecture designed by Ibrahim et al. [56] has been used to develop a GUI as shown 
in Figure 3. The user interface is comprised of a few dialog boxes and radio buttons that request 
patient information and input data for the prediction process. The patient information includes patient 
identification and gender. The radio buttons are used to simplify user selection of the symptoms and 
the signs presented by the dengue patients. The “predict the day of defervescence of fever” button 
gives the estimated day of fever reduction. The entire system was compiled to function as a standalone 
application that can be used in any computer environment. 
 
Figure 3. Graphic interface screen for the prediction of day of defervescene of fever in 
dengue patients. 
Ibrahim et al. [39] introduced a novel approach to classify the risk in DHF patients by using the 
BIA technique. A total of 184 (97 males and 87 females) serologically confirmed dengue patients 
(DHF I–IV) were studied during their hospitalization. The relationship between gender and group with 
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the biological electrical tissue conductivity BETC parameters was studied employing univariate 
analysis of variance. The experimental results showed that BETC, specifically the reactance, was a 
potentially useful tool in classifying the risk factor of DHF patients.  
The work by Ibrahim et al. [39] has been extended to diagnose the risk in dengue infections using 
an artificial neural network technique [57]. The study employed MLFFNN for classifying the risk 
stages in dengue patients. In this study, the severity of risk in dengue disease was quantified using the 
dengue patients’ blood data based on threshold values obtained from other researcher’s findings and 
the WHO classification system [58]. Data comprises of 223 healthy subjects and 207 dengue patients 
were arranged randomly into the training and testing in the ratio of 70:30. The ANN was trained via 
the steepest descent back propagation with momentum algorithm method. The optimum network 
architecture was determined by optimizing the training parameters. The optimization criteria was the 
sum squared error (SSE) and total classification accuracy of the network. The total classification was 
subjected to a 25% error tolerance. After the optimal ANN structure was determined, it was pruned using 
a weight eliminating method to enhance the system performance. The overall classification accuracy was 
96.27% with 95.88%, 96.83%, and 95.81% for high risk, low risk, and healthy groups, respectively. 
Continuing research has taken the neural network architecture obtained from Ibrahim et al. [57]. 
and developed an automatic dengue risk classification. Using the Matlab software, a GUI has been 
developed for use in real clinical applications as shown in Figure 4. The user interface is comprised of 
a few dialog boxes and radio buttons that request patient information and input data for the diagnosis 
process. The DIAGNOSE button is used to initiate MLFFNN calculation for each given input. The 
system produces one of three outcomes: healthy, low risk, or high risk; and the result is displayed in 
the bottom most dialog box. 
The same technique and the same data were used by Faisal et al. [59] to develop a non-invasive 
intelligent technique for diagnosing the risk stages in dengue patients using clinical manifestations 
(signs and symptoms) and the BIA measurements. An accuracy of 70% with 0.121 sum squared error 
was achieved by this model. The study concluded that such a screening system can aid physicians in 
the diagnosis of the risk and the prognosis of dengue patients, but it will not be definitive. 
Although the Multi-Layer Perceptron (MLP) trained via the back propagation (BP) algorithm has 
demonstrated significant good performance in classification and prediction applications compared to 
statistical analysis, it suffers from a slow convergence rate and often yields suboptimal  
solutions [60,61]. To overcome this drawback, many researchers have employed the Levenberg-Marquardt 
(LM) algorithm [62] or Scaled Conjugate Gradient (SCG) algorithm [36] for training the MLP since 
these methods provide faster convergence and better estimation results. Those algorithms have been 
successfully used in medical applications for classifying and diagnosing several diseases. 
Faisal et al. [59] constructed the dengue patient diagnostic model using the LM and SCG 
algorithms. Systematic procedures involving training, testing, and validation were followed to 
construct the diagnostic model so that a higher performance of the diagnostic model can be achieved 
and the robustness of overall diagnostic models can be maintained. Precise tuning of the internal 
training algorithms’ parameters was performed to attain the optimal model. Three-layer network is 
used. The activation function in hidden layer’s neurons is hyperbolic tangent sigmoid while in the 
output layer’s neurons are sigmoid transfer function. The 5-fold Cross Validation (CV) technique is 
implemented. The data are divided into five sets; each set contains 101 samples (45 high risk patients, 
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56 low risk patients). Four sets (404 samples) were used for training and the remaining set was used 
for testing. The training process was repeated for five times, at each time one of the sets was used as 
testing set. The results for optimization of the MFNN trained via the Levenberg-Marquardt algorithm 
showed that the optimal model achieved an average diagnostic accuracy of 70.7% with 73% 
sensitivity, 74% specificity and a 0.02 average MSE. By implementing the scaled conjugate gradient 
algorithm, the optimal diagnostic model achieved an average diagnostic accuracy of 75% with 0.01957 
average MSE. 
 
Figure 4. An Automatic dengue risk diagnostic system using artificial neural networks and 
bioelectric impedance analysis techniques. 
Adaptive Neuro-Fuzzy Inference System (ANFIS) 
Even with the success of ANNs in a decision support system, the use of computerized decision 
making systems in clinical medicine is rather difficult due to the uncertainty of naturally occurring 
diseases. In such a situation, fuzzy set theory appears as an appropriate tool for a decision making 
system since it deals with uncertainty by applying our knowledge and experience directly without any 
explicit mathematical models. Fuzzy logic describes human thinking and reasoning in a mathematical 
framework by using several rule bases (IF-THEN) that require a number of human experts to carefully 
define the rules. Even though the fuzzy logic has been successfully implemented, there are some basic 
aspects of it that are in need of better understanding. First, the need for a standard method for 
transforming human knowledge or experience into the rule base and database of a fuzzy inference 
system is noted. Second, there is a need for effective methods for tuning the membership  
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functions [63]. Based on those needs, the Adaptive Neuro-Fuzzy Inference System (ANFIS) was 
proposed to serve as a basis for constructing a set of fuzzy if-then rules with appropriate membership 
functions to generate the stipulated input-output pairs [63]. 
Faisal et al. [64] utilized (ANFIS) to develop a dengue patient diagnostic model. The development 
of the model was carried out in two steps: defining the initial ANFIS model architecture and training 
of the defined model. Two approaches were followed to define the initial ANFIS model architecture. 
In the first approach, the number of membership functions in the inputs and the output were 
systematically varied and the effect of this variation in the model performance was investigated. In the 
second approach, a subtractive clustering algorithm was assigned to determine the initial ANFIS model 
by optimizing the number of membership functions and fuzzy rules. After the initial model structure 
was defined, it was trained so that the differences between the output obtained from the model and 
actual output are minimized. The hybrid learning algorithm was employed for this task. The results of 
the first approach showed that the highest overall accuracy of 80.19% with 71% sensitivity and 86% 
specificity was achieved. For the second approach, average diagnostic accuracy was 86.13% with 
87.5% and 86.7 sensitivity and specificity, respectively. 
The graphic user interface for the new ANFIS is shown in Figure 5. The user interface is comprised 
of four parts: patient information such as patient's identification, symptoms and signs, the bioelectrical 
impedance data, and the dengue patient risk diagnostic which determines the level of risk in  
dengue patients. 
 
Figure 5. Dengue patient diagnostic system based on Adaptive Neuro-Fuzzy Inference System.
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2.1.7. Dengue Fever Detection Using Microfluidic Lab-On-a-Disc (LOD) and  
Lab-On-a-Chip (LOC) Platforms 
Microfluidic devices have been proposed as a solution to overcome the many problems caused by 
the conventional dengue testing systems such as the high cost, reagent consumption, long turnaround 
time and complex procedures. Lab-on-a-disc (LOD) and lab-on-a-chip (LOC) are the most popular 
microfluidic platforms that have been reported by many researchers as a portable diagnostic device for 
dengue detection [65–67]. 
Ibrahim et al. [68] and Yusoff et al. [69] have discussed the fundamentals of the microfluidic 
compact disc (CD) and its application as a platform for ELISA detection of dengue non-structural 
glycoprotein 1 (NS-1), and Ibrahim et al. [68] designed and fabricated a microfluidic CD to 
automatically perform an ELISA test for dengue detection. 
On the other hand, lab-on-a-chip (LOC) has been proposed as a precise, rapid, and low cost 
platform for dengue detection [70,71]. Lee et al. [70] reported an integrated microfluidic platform that 
can detect the dengue virus by coating magnetic microbeads with antibody. A multi-way micropump 
shown in Figure 6 is used for moving the serum sample, reagents and other buffers inside the 
microfluidic net (channels and chambers). Lee et al. [72] claimed that the time required to perform one 
test is 30 min, which is only 1/8th of the time required to detect dengue using a conventional testing 
platform. Wenget al. [71] reported a new microfluidic LOC platform for dengue detection where a 
suction method (instead of pumping) is used to move the liquid inside the device. 
Polydimethylsiloxane (PDMS) has been used for the chip fabrication and the surfaces are  
pre-functionalized to minimized protein adsorption. The dengue testing process can be finished within 
30 min and the chip can stay stable for one month if it is stored at 4 °C. 
 
Figure 6. The magnetic bead-based microfluidic chip measures 53 mm × 37 mm. 
Reproduced with permission [72]. 
2.1.8. Dengue Virus Detection Using Paper-Based-Diagnostic Platform 
The lab-on-paper, or paper-based diagnostic platform is a recently developed low cost method of 
implementing point of care diagnosis. The paper-based devices are easy to use, low cost, disposable, 
and can be used for a wide range of biomedical diagnosis [73–75]. 
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A medical patch developed by Martinez et al. [73] allows for the use of chromatography paper  
as a low cost, low volume, and portable bioassay. The paper is patterned with test areas which are  
doped with the required reagents, which change in color when it reacts with the intended analytes. 
Matthews et al. [74] further enhanced the paper-based platform by developing an object identification 
algorithm that is light enough for use on mobile phones. The application utilizes the built-in camera of 
mobile phones for image capturing of the medical patch developed by Martinez et al. [73]. Once the 
image is captured, a developed mobile application then performs the necessary image processing and 
determines the disease state. 
In a novel study conducted by Lo et al. [75], dengue virus is detected on a paper-based device for 
the detection of dengue virus by first amplifying the nucleic acids via reverse transcription loop-mediated 
isothermal amplification (RT-LAMP), then analysing the results using a colorimetric assay on paper. The 
process of RT-LAMP is performed on Dengue serotype-2 ribonucleic acid (RNA) using conventional 
microwell assay technique. Once the RT-LAMP process is completed, the DNA product is then 
dropped on a waxed patterned 96-well paper where it is mixed with biotin-11-deoxyuridine, and then 
conjugated with streptavidin horseradish peroxidase. The 96-well paper is then washed and scanned to 
obtain the colorimetric results on a computer.The study concluded that the combination of RT-LAMP 
andpaper-based colorimetric approach reduces the process time, while requiring very little sample 
volume and is suitable for the point-of-care application. 
2.2. Summary 
The summaries of biomedical engineering techniques in dengue disease are listed in Tables 2–4.  
Table 2 summarizes the biomedical engineering techniques of ultrasound, echocardiography and 
electrocardiography (ECG), strain gauge plethysmography, laser Doppler velocimetry and bioelectrical 
impedance in dengue disease. Table 3 summarizes the biomedical engineering techniques in dengue 
clinical decision support systems. Table 4 summarizes the biomedical engineering techniques for dengue 
fever detection using microfluidic lab-on-a-disc (LOD), lab-on-a-chip (LOC), and paper-based platforms. 
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Table 2. Summary of biomedical engineering techniques of ultrasound, echocardiography and electrocardiography (ECG), strain gauge 
plethysmography, laser Doppler velocimetry and bioelectrical impedance in dengue disease. 
Authors Year Studies Methods Findings/Results 
Srikiatkhachorn  
et al. [18] 
2007 
To delineate the locations and timing of 
plasma leakage in DHF cases 
Ultrasound 
The Pleural effusion was the most common 
ultrasonographic sign of plasma leakage  
in dengue infection 
Venkata et al. [19] 2005 
Determination of the usefulness of 
ultrasound in dengue disease severity  
in patients 
Ultrasound 
Thickened gall bladder wall, pleural effusion,  
and ascites should strongly favor the  
diagnosis of dengue fever 
Setiawan et al. [20] 1989 
Examination of sonographs to identify 
the relationship between the clinical 
severity of DHF patients grades I/II and 
grades III and IV. 
Ultrasound 
Pleural effusions, ascites and gallbladder wall 
thickening, pararenal and perirenal fluid collections, 
hepatomegaly, and pancreatic gland enlargement are 
detected in in DHF patients grades III and IV 
Pelupessy et al. [21] 1989 
Utilization of echocardiography to 
diagnose dengue patients 
Echocardiography and 
electrocardiography (ECG) 
No signs of pericardial effusion could be determined on 
physical examination of DHF patients associated with 
severe shock. However echocardiogram results were able 
to clearly show a small amount of fluid. 
Wali et al. [22] 1998 
Assessment of cardiac function of DHF 
and DSS patients 
Radionuclide 
ventriculography, 
echocardiography, and ECG 
Acute reversible cardiac insult may be noticed  
in DHF/DSS and could be responsible for 
hypotension/shock seen in some patients. 
Yusoff et al. [23] 1993 
Investigation of echocardiograms and 
ECGs in healthy and dengue patients 
Echocardiography and 
electrocardiography (ECG) 
ECG and echocardiographic abnormalities are common 
during the acute phase of DHF which can be used as 
early detection 
Gamble et al. [24] 2000 
Investigation of age-related changes in 
microvascular permeability in  
dengue patients 
Strain Gauge 
Plethysmography 
Children are more susceptible to develop hypovolaemic 
shock than adults in DHF 
Bethell et al. [25] 2001 
Assessment of microvascular to 
differentiate children with DSS, DHF 
without shock, and healthy children 
Strain Gauge 
Plethysmography 
The microvascular permeability for patients with dengue 
was 50% higher compared to healthy patients. However, 
there was no significant difference in the permeability 
between the DSS, DHF dengue patients 
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Table 2. Cont. 
Authors Year Studies Methods Findings/Results 
Hassan et al. [30] 2003 
Evaluation of microcirculation changes 
due to plasma leakage and increase of 
microvascular permeability in  
DHF patients 
Laser Doppler Velocimetry 
The technique can differentiate between normal healthy 
subjects and DHF patients, but cannot clearly identify 
the DHF severity stages 
Klassen et al. [42] 2000 
Determining the hydrational profile in 
dengue patients 
Bioelectrical Impedance 
Body impedance can be used to monitor the dengue 
fever progression. 
Fang et al. [45] 2010 
Detection of dengue fever from  
patient serum 
Biosensor 
The impedance changes in correlation with 
concentrations of dengue antibody in serum samples 
Ibrahim et al. [46] 2004 
Modeling of hemoglobin (Hb) status in 
dengue patients using the  
BIA parameters 
Multiple-linear-regression 
analysis 
Accuracy of 42% was achieved for modeling  
the Hb variation 
Ibrahim et al. [46] 2008 
Modeling of hemoglobin (Hb) status in 
dengue patients using BIA parameters 
Artificial Neural Network 
(ANN) 
Accuracy of 74% was achieved for modeling  
the Hb variation 
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Table 3. Summary of biomedical engineering techniques in in dengue clinical decision support systems. 
Authors Year Studies Methods Findings/Results 
Ibrahim et al. [39] 2005 
Classification of dengue patients 
based on disease severity 
Multilayer Feed-Forward  
Neural Networks 
Classification was achieved with accuracy 
96.27%, sensitivity 95.88%, specificity  
96.83%, and 25% error tolerance 
Faisal et al. [47] 2008 
Distinguish between dengue 
patients and healthy subjects using 
self-organizing map 
Self-organizing map 
4 significant bioelectrical impedance  
parameters and 3 signs/symptoms were  
defined to distinguish between the two groups. 
Faisal et al. [55] 2010 
Determination of classification 
criteria to classify the severity of 
dengue disease 
Self-organizing map 
Three criteria were defined to classify the  
level of risk in dengue patients. 
Faisal et al. [59] 2010 
Classification of dengue patients 
based on disease severity 
MFNN trained via the  
Levenberg-Marquardt algorithm 
Classification was achieved with accuracy  
70.7%, sensitivity 67%, specificity 74% 
Faisal et al. [59] 2010 
Classification of dengue patients 
based on disease severity 
MFNN trained via Scaled 
Conjugate Gradient algorithm 
Classification was achieved with accuracy  
75%, sensitivity 73%, specificity 74% 
Faisal et al. [64] 2012 
Classification of dengue patients 
based on disease severity 
Adaptive Neuro-Fuzzy  
Inference System 
Classification was achieved with accuracy 
80.19%, sensitivity 71%, specificity 86% 
Faisal et al. [64] 2012 
Classification of dengue patients 
based on disease severity 
Adaptive Neuro-Fuzzy  
Inference System with subtractive 
clustering algorithm 
Classification was achieved with accuracy  
86.13%, sensitivity 87.5%, specificity 86.7% 
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Table 4. Summary of biomedical engineering techniques of microfluidic lab-on-a-disc (LOD), lab-on-a-chip (LOC), and paper-based 
platforms in dengue disease. 
Authors Year Studies Methods Findings/Results 
Ibrahim et al. [68] 2010 
Investigation of the viability of the  
microfluidic CD as a platform for ELISA 
Microfluidic Lab-on-a-Disc 
Automated sequencing of ELISA for NS-1 
detection can be accomplished on the CD 
Yusoff et al. [69] 2009 
Development of microfluidic CD  
as a platform for ELISA 
Microfluidic Lab-on-a-Disc 
Demonstrated a CD design for automated 
ELISA testing for Dengue NS-1. 
Lee et al. [70] 2009 
Investigation of antibody coated  
magnetic microbeads for speeding up the 
ELISA process on the microfluidic CD 
Microfluidic Lab-on-a-Chip 
with Microbeads 
Dengue testing time was reduced to  
30 min (1/8th of the time compared to 
conventional 99-microwell method for  
IgM and IgG ELISA) 
Weng et al. [71] 2011 
Investigation of suction based  
pumping in microfluidic platform to  
speed up the ELISA process 
Microfluidic Lab-on-a-Chip
Dengue testing time is reduced to  
30 min for IgG ELISA test 
Martinez et al. [73] 2007 
Investigation of patterned chromatography 
paper for Dengue detection 
Paper based 
Paper based bioassay changes  
color during detection. 
Lo et al. [75] 2009 
Development of object identification algorithm 
on mobile phones for analysing the paper based 
patch developed by Martinez et al. [73] 
Paper based 
Image captured by the mobile  
application is processed and the  
disease state is determined 
Matthews et al. [74] 2007 
Development of waxed patterned 96-well  
paper to perform Dengue virus detection. 
Paper based 
The 96-well paper allows for  
colorimetric detection that reduces the 
process time, while requiring very little 
sample volume and is suitable for  
the point-of-care application. 
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3. Malaria 
Malaria is an infection that affects humans and some animals and is transmitted by infected female 
Anopheles mosquitoes. Fever, headache, and in some severe cases patients progressing to coma or 
death, are the common symptoms of this disease. Sub-Saharan Africa, Asia, and the Americas are the 
areas where malaria is most prevalent [4]. In general, five types of the plasmodium have the capability 
of causing human infection: P. falciparum, P. vivax, P. ovale, P. malariae, and P. Falciparum are 
mainly found in Africa and some parts of Asia and South America [76]. P. falciparum is the common 
cause of severe malaria cases that can lead to death. P. vivax is less fatal but can lead to serious anaemia 
in children. Two hundred sixteen million cases of malaria were reported in 2011, where 81% of those 
cases were found in Africa [4]. It is estimated that around 86% of these cases are children under 5 years 
of age. The two common methods for diagnosis of malaria are light microscopy of blood and the rapid 
diagnostic tests (RDTs) [77]. The main advantage of the light microscopy is the low cost in endemic 
areas. However, the need for a highly trained operator and the lack of portability are the main 
drawbacks. RDT testing kits are preferable in other areas but the cost of the RDT kits is high. 
3.1. Biomedical Engineering Approaches 
Several biomedical engineering approaches for malaria detection have been described including 
microfluidic systems, image processing, and bioelectrical properties of blood. The following sections 
review these approaches. 
3.1.1. Image Processing 
Many researchers have reported the auto-detection of malaria infection by utilizing image 
processing techniques on microscopy images [78–85]. This work is based on images of cultured 
malarial parasites that were grown under a controlled environment rather than in patients’ blood.  
Rao [85] utilized the stained images of the P. falciparum to analyse its life cycle. At a later study by 
Sio et al. [83], new software that automatically counts the malarial parasite has been reported. The 
software focused on the counting of P. falciparum in images where the regular blood components and 
other types of noise are not present. The algorithm applied is able to differentiate between infected and 
uninfected red blood cells, and successfully count the parasites from peripheral blood specimens. 
Dimension and colour of components were used for identification. Halim et al [80] performed 
template matching techniques to detect red blood cells (RBC). Gray scale images were processed using 
different image process techniques for parasite detection. The second developed method utilizes the 
colour co-occurrence array that analyzes pixel colour index and the indicated colour of the surrounding 
pixels. The various techniques produced results with accuracy of 80%–88% and a sensitivity of  
92%–98%. 
3.1.2. Microfluidics 
The portability and the small volume of sample required to perform a test are the main advantages 
of the microfluidic platforms [86]. These features, along with the low cost of the microfluidic platform 
make it ideal to be used on site and in resource-limited areas.  
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Different immunochromatographic methods (dipstick) of malaria infection detection have been 
described [87,88]. These platforms are easy to use, portable, and can be used in the most challenging 
environments. Most are based on the detection of malaria antigens from a patient’s blood sample.  
The targeted antigen types include histidine-rich protein-2 (HRP-2), aldolase, and plasmodium lactate 
dehydrogenase (pLDH). The developed methods have the ability to differentiate between the main 
malaria types through the immunogenic differences in the proteins. Figure 7 shows an example of a 
microfluidic platform (dipstick) that utilizes immunochromatographic lateral flow to detect malarial 
proteins (antigen (Ag)) that are extracted from patient blood [89]. The disadvantage of the microfluidic 
platforms is their accuracy which is less than that from gold standard microscopy techniques [90,91].  
As the disease severity declines, the concentration of malarial antigens quickly decreases. Therefore, 
these detection techniques are good for detection of recurrent infection and not for observing the 
response of the patient to treatment. 
 
Figure 7. Schematic of the lateral flow strip to diagnose Malaria. (top) Layout of the strip, 
(middle) Flushing agent is added to help flush parasitized blood along the strip, and 
(bottom) visible lines indicate presence of antigens in the parasitized blood. Reproduced 
with permission [89]. 
Many platforms were proposed using the flow cytometry approaches for malaria detection have 
been reported [92,93]. Saito-Ito et al. [93] presented a fast, high sensitivity, and low error diagnostic 
platform that is capable of detecting the P. falciparum from a sample that contains erythrocytes and 
stained parasites. The sensing principle was based on forward-angle light scattering from an argon 
laser, and green fluorescence was utilized in this process. The author claimed that the required time to 
perform a full test is 2–3 min including sample preparation. Jiménez-Díaz et al. [94] proposed a new 
flow cytometric platform for malaria detection based on observing the differences of infected 
erythrocytes stained auto-fluorescence and DNA content with that of healthy cells. The author claimed 
that the proposed platform is rapid, simple to use, sensitive, and can accurately detect malarial pathogens. 
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3.1.3. Paper-Based Microfluidic Cartridge 
A method of paper-based microfluidics has been reported to prepare stained malaria parasites for 
detection using traditional optical microscopy [95]. Horning et al. [95] presented a paper microfluidic 
cartridge for automated staining of malaria parasites. The cartridge is similar to a dipstick, but replaces 
the cellulose strip with paper. Blood is dropped onto a piece of dyeing hydrophilic paper which stains 
the malaria parasites. The blood is then channeled by capillary forces through the paper into an 
optically transparent slanted chamber which gradually get thinner. The slanted chamber produces a 
thick smear near the paper, and a thin smear towards the end of the chamber. The cartridge can then be 
examined using traditional optical microscopy. The authors claimed that the device is easy to use, fast, 
low cost, has good optical properties, and is suitable for automated microscopy. A comparison with the 
standard Giemsa smear technique has shown that the cartridge produces smears equal to that of a blood 
smear as prepared on a microscope slide by an expert microscopist. 
3.1.4. Microarray Chip 
Recently, Jin et al. [96] proposed a microwell array chip that enables the analysis of single live 
cells. The proposed system is capable to analyze more than 234,000 individual cells rapidly and efficiently.  
 
Figure 8. Schematic diagram of the process for detection of malaria-infected erythrocytes 
on a cell microarray chip. (a) Erythrocytes stained with a nuclei-specific fluorescent dye, 
SYTO 59, for the staining of malaria nuclei dispersed on a cell microarray chip using a 
pipette, which led to the formation of a monolayer of erythrocytes in the microchambers;  
(b) Malaria-infected erythrocytes were detected using a microarray scanner with a  
confocal fluorescence laser by monitoring fluorescence-positive erythrocytes; (c) The 
target malaria-infected erythrocytes were analyzed quantitatively at the single-cell level. 
Reproduced with permission [97]—open access. 
Expanding on the work of Jin et al. [96], Yatsushiro et al. [97] reported a novel high-throughput 
screening and analysis system for malaria infection using microarray chip with a laser scanner (Figure 8). 
They utilized a polystyrene chip that contains 20,944 micro-chambers fabricated using molding 
techniques. The author claimed that the system is 10 to 100 times more sensitive than the conventional 
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light microscopy diagnosis method. This system requires 15 min to detect malaria parasites in erythrocytes 
extracted from centrifuged blood. 
3.1.5. Dielectrophoresis (DEP) 
Dielectrophoresis (DEP) technology is utilized by many researchers for cell manipulating and 
characterization [98]. DEP is the phenomenon that describes the motion of polarizable particles in a  
non-uniform electric field. It allows for the recognition of differentiated populations of particles based 
on their relative polarisibility. Separation between the living and dead cells is an example of 
application of DEP; taking advantage of the unique electrical properties of each bioparticle [99].  
Aceti et al. [100] found that the dielectric properties of erythrocytes infected with the malarial parasite  
P. falciparum are different from normal erythrocytes. The electrical conductivity of the erythrocyte 
membrane increases sharply when it is infected with Malaria parasites. This sharp increase was due to 
changes in the composition, morphology and permeability of the erythrocyte membrane. Therefore, 
Gascoyne et al. [101] utilized the DEP technique to separate the malarial infected cells from the 
healthy cells by dielectrophoretic manipulation in a non-uniform electric field. Only a few microliters 
of blood are required to detect malaria on the DEP platform. 
3.1.6. Bioelectrical Properties 
Lonappan et al. [102] studied the microwave characteristics of malaria and normal blood samples 
using a cavity perturbation technique. This method has many advantages such as its simplicity, rapid 
performance, reliable results and the small sample volume required to run the test. A significant 
difference of the conductivity of malaria blood samples when compared with the normal healthy 
samples was seen at frequencies of 2 to 3 GHz. This measurement is a new novel in vitro method of 
diagnosing malaria at its onset using microwaves, and it will allow precautions to be taken early in the 
disease course such as proper preventative drugs, which will improve disease prognosis [102]. 
Wilson et al. [103] developed an integrated system with dark-field reflection-mode and cross 
polarization microscopy for the detection of hemozoin in fresh blood samples. Hemozoin is an  
iron-containing pigment resulting from the breakdown of haemoglobin, found in the malaria parasite. 
The presence of hemozoin results in a different light scattering effect when compared to healthy RBCs. 
The result shows that incorporating both methods doubles the contrast when compared to the 
individual techniques [103]. 
3.2. Summary 
The summary of biomedical engineering techniques in malaria disease is listed in Table 5. 
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Table 5. Summary of biomedical engineering techniques in malaria disease. 
Authors Year Studies Methods Findings/Results 
Halim et al. [80] 2006 
Development of template matching techniques 
for detection of infection in blood smears. 
Image processing 
Various image processing techniques presented yield a detection accuracy 
of 80%–88% with a sensitivity of 92%–98% 
Sio et al. [83] 2007 
Development of algorithm to automatically count 
malarial parasites in images of  
filtered blood samples 
Image processing 
The algorithm is able to differentiate between infected and uninfected red 
blood cells, and successfully counts the parasites in peripheral  
blood specimens. 
Saito-Ito et al. [93] 2001 
Development of a fast, high sensitivity, and low 
error diagnostic platform using light scattering in 
flow cytometry 
Microfluidics—Cytometry Allows for a full test to be performed in 2–3 min including sample preparation 
Jiménez‐Díaz et al. [94] 2005 
Development of flow cytometric method based 
on measuring autofluorescence and DNA content 
in stained infected erythrocytes 
Microfluidics—Cytometry 
The proposed platform is rapid, simple to use,  
sensitive, and can accurately detect malarial pathogens. 
Horning et al. [95] 2014 
Development of dipstick-like paper microfluidic 
cartridge for automated staining of  
malaria parasites 
Microfluidics—Paper-based 
The device produces results that are comparable to the  
standard Giemsa smear technique, and has good optical properties to be 
examined using traditional optical microscopy. 
Yatsushiro et al. [97] 2010 
Development of high-throughput screening and 
analysis microarray chip 
Microarray chip 
The microarray chip containing 20,944 chambers allows for 10 to 100 times 
higher sensitivity compared to conventional microscopy. It only takes  
15 min to detect malaria parasites in erythrocytes extracted from 
centrifuged blood. 
Aceti et al. [100] 1990 
Investigation of dielectric properties of 
erythrocytes infected with the malarial parasite 
Dielectrophoresis 
Electrical conductivity of erythrocyte membrane increases sharply  
when infected 
Gascoyne et al. [101] 2002 
Investigation of identifying malarial infected 
cells using dielectrophoretic 
Dielectrophoresis 
Cell separation allows maria detection using only a few microliters  
of blood 
Lonappan et al. [102] 2009 
Investigation of microwave characteristics of 
malaria infected and normal blood samples 
Bioelectrical 
Using a cavity perturbation technique, significant difference of the 
conductivity can be detected between malaria infected blood samples and 
normal healthy samples at frequencies of 2 to 3 GHz. 
Wilson et al. [103] 2011 
Assessment of dark-field reflection-mode and 
cross polarization microscopy in  
malaria detection 
Bioelectrical 
Hemozoin (found in malaria parasite) has a light scattering effect that 
doubles the contrast in cross polarized microscopy images 
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4. Cholera 
Cholera is an acute intestinal infection as a result of ingestion of food contaminated with the vibrio 
cholerae bacteria. This infection has a short period of incubation from two to three days. If treatment is 
not administered immediately, it causes an enterotoxin that leads to vomiting and excessive flowing 
diarrhea that results in extensive dehydration. According to the WHO, the incidence of cholera has 
been growing, with approximately 317,000 cases and 7500 deaths in 2010, demonstrating an increase 
of 43% in the number of cases and 52% in the number of deaths compared to 2009 [6]. In areas where 
cholera is endemic, the mortality rate has increased for children and pregnant women. Two types of 
vaccines are available to protect against this disease, and it is easily treated by intravenous  
rehydration [104]. 
Although standard culture methods can be employed for detection of v. Cholera, limitations 
including low accuracy, the requirement of expertise and well equipped laboratory, and lengthy time 
for diagnosis make it impractical in diagnosis of individual cases. Dark field microscopy and a dipstick 
assay can be used to achieve a fast identification of v. Cholerae. These assays can yield results that 
differ with the definitive culturing methods, therefore fluorescent monoclonal antibody and PCR-based 
techniques have been developed to improve sensitivity and specificity of the assays [105]. 
4.1. Biomedical Engineering Approaches 
A few biomedical approaches have been investigated to improve the detection of cholera toxin (CT). 
4.1.1. Microfluidics 
Bunyakul et al. [106] developed a microfluidic platform incorporating fluorescence and 
electrochemical detection techniques for the detection of cholera toxin subunit B (CTB). The 
microfluidic platform was fabricated using soft lithography on polydimethylsiloxane (PDMS). The 
sample with CTB concentrations of up to 1000 ng/mL is injected into the platform towards a capture 
zone withCTB-antibodies and ganglioside GM1 receptor immobilized onto magnetic beads. The beads 
are then immobilized using an external magnet for washing and then transferred to a detection zone for 
either fluorescence detection, or electrochemical detection. The implementation of the microfluidic 
platform allows for limits of detection of 6.6 and 1.0 ng·mL−1 respectively for the fluorescence and 
electrochemical techniques. 
4.1.2. Impedance Techniques 
Due to the low levels of lethal dose (LD) in humans [107], there is a high demand for detection 
techniques capable to discriminate very low concentrations of the toxin. Labib et al. [108] developed 
an immunosensor assay for the detection of CTB using a capacitive method. The sensor consists of a 
gold electrode coated with monoclonal antibodies against CTB (anti-CTB) inserted into a capacitive 
flow cell. Potential pulses of 50 mV at 50 Hz are transmitted through the capacitive flow cell, and the 
transient currents evoked between the electrode and the capacitive flow cell are recorded and used to 
calculate the capacitance of the liquid. The capacitance value recorded is found to decrease when CTB 
binds with the anti-CTB coating on the electrode. 
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4.2. Summary 
The summary of biomedical engineering techniques in cholera disease is listed in Table 6. 
Table 6. Summary of biomedical engineering techniques in cholera disease.  
5. Schistosomiasis 
Schistosomiasis is a type of parasitic infectious disease affecting at least 230 million individuals per 
year in developing countries. It is caused by the trematode parasite worms, of the genus schistosoma. 
The disease is classified into two major types; (a) intestinal schistosomiasis caused by S. guineensis,  
S. mekongi, S. mansoni, S. japonicum, and S. intercalatum, and (b) urogenital schistosomiasis caused 
by S. haematobium. Rapid multiplication and transmission of the schistosoma parasites lead to more 
infected people each year. Furthermore, there is a high mortality rate of this disease, above 200,000 
deaths per year in sub-Saharan Africa [5]. Shistosomiasis infection happens when parasites in larval 
forms produced by snails in fresh water, penetrate the skin, often of the feet, that is exposed to infested 
water. The larva then turns into mature schistosomes in the body. The adult female worms can produce 
eggs in the blood vessels causing immune reactions and damaging tissues while others get out of the 
body through urine or faeces. 
In women, urogenital schistosomiasis can be considered as one of the risk factors for being infected 
by human immunodeficiency virus (HIV). The body does not react to the worm but to the worm’s 
eggs. Intestinal schistosomiasis can cause abdominal pain, diahrrea, enlargement of the liver, blood in 
the stool, fluid accumulation in the peritoneal cavity, abdominal hypertension, and spleen enlargement. 
Urogenital schistosomiasis, on the other hand, can cause haematuria, bladder and ureter fibrosis, 
damage to kidney, and bladder cancer (as a possible late-stage complication). 
Microscopic identification of eggs in specimens of stool or urine is the most efficient technique for 
Schistosomiasis diagnosis. For detection of shistosomiamansoni and shistosomiajaponicum, only 
microbiological methods such as the Kato-Katz technique can be applied. The severity of infection rate 
is determined based on the number eggs per gram of stool sample [109]. However, this diagnostic test 
is time-consuming, costly, and requires the skill of a trained parasitologist; all of which limit its utility 
in the developing world. 
5.1. Biomedical Engineering Approaches 
The following sections demonstrate the most common biomedical engineering approaches for 
diagnosis and prognosis of schistosomiasis including: bioelectrical impedance analysis (BIA), 
Authors Year Studies Methods Findings/Results 
Bunyakul et al. [106] 2009 
Investigation of fluorescence and 
electrochemical detection for 
CTB on microfluidic platform 
Microfluidics 
Limits of detection of 6.6 ng/mL and 1.0 ng/mL are 
achievable respectively using the fluorescence and  
electrochemical techniques. 
Labib et al. [108] 2009 
Development of capacitive 
immunosensor assay for CTB 
detection 
Capacitive 
Impedance 
Measurement 
When a 50 mV 50 Hz signal is applied to the 
immunosensor (constructed from coated gold  
electrode in a capactive flow cell), the capacitance of 
the immunosensor decreases if CTB is present. 
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ultrasound, computerized tomography (CT), and magnetic resonance imaging (MRI). Imaging techniques 
are considered as one of the most rapid, reliable, and accurate methods for detection of schistosomiasis. 
5.1.1. Bioelectric Impedance Analysis (BIA) 
BIA is an efficient method to assess the total body water (TBW) and its distribution between ECW 
(Extracellular Water) and ICW (Intracellular Water), and it has been shown that BIA is sensitive to 
TBW percentage alterations and the ECW to ICW ratio [110] that can provide an easy, inexpensive 
analysis of body composition. In De Lorenzo et al.’s [110] study, body hydration, being defined as 
total body water per kg of body weight, is considerably higher in patients with schistosomiasis than in 
normal controls. De Lorenzo et al. [110] recruited schistosomiasis patients without clinical symptoms 
such as no visible fluid retention, no cardiac or renal abnormalities from the underlying disease. BIA 
was used to measure the amount of TBW and it was found that the percentage of body water is higher 
in patients with schistosomiasis than in controls (62.9% ± 3.6% vs. 57.4% ± 4.3%, p < 0.0005). 
Although, these patients’ anthropometric characteristic was similar with the control group, their 
TBW% was higher. De Lorenzo et al. [110] discusses that various reasons may have partially 
contributed the increased subclinical alterations in body hydration in patients with schistosomiasis. For 
example, the subclinical alterations may be due to the arm fat area of schistosomiasis patients being 
reduced to 20% lower than the control group [110]. However, it is observed that difference in TBW% 
is small and may not be sufficient to allow a classification. 
Hypoalbuminaemia is a cause of oedema. In the absence of fluid retention, albumin levels <1.5–2 g/dL 
are required to have a clinically detectable increase of in ECW relative to TBW (ECW%) [111].  
In De Lorenzo et al.’s [110] findings, one of the schistosomiasis patients experienced a 1.9 g/dL and 
higher level with the absence of oedema. The findings suggest that albumin is vital in controlling body 
water homeostatis in conditions of normal and subclinically altered body hydration. The findings 
concluded that schistosomiasis subjects show an apparent subclinical increase in body hydration which 
is related to the prediction of TBW from BIA. 
5.1.2. Ultrasound Imaging of Hepatosplenic-Schistosomiasis 
Ultrasound (US) is known to be one of the most effective methods for investigating liver and spleen 
abnormalities caused by schistosomamansoni. Portal hypertension induced by the periportal fibrosis is 
shown to be one of the main characteristics of the hepatosplenic form of schistosomiasis, it can be 
demonstrated by ultrasound imaging through measurement of the diameter of the portal vein and its 
main tributaries (splenic vein and superior mesenteric vein). Hepatosplenic schistosomiasis can induce 
formation of collateral vessels in the gastrointestinal tract leading to acute bleeding or possibly death. 
This phenomenon can be demonstrated by ultrasound imaging indicating an increased risk of bleeding 
(Figure 9). Ultrasound can also be applied as a diagnostic tool in the assessment of treatment efficacy 
and regression of fibrosis in schistosomiasis [112,113]. 
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Figure 9. Ultrasound B-scans of the abdomen showing changes caused by schistosomiasis. 
White arrow: Central periportal fibrosis, red arrows: fibrosis on the periphery of the liver 
in a patient diagnosed with advanced hepatosplenic schistosomiasis Reproduced with 
permission [112]. 
5.1.3. Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI) 
Diagnosis of hepatosplenic Schistomiasis can be obtained by observing characteristic changes of the 
attenuation in the computerized tomography (CT) or signal intensity and enhancement pattern of the 
magnetic resonance images (MRI) [112,114]. The CT and MRI findings are usually compared and are 
in agreement with the ultrasound findings. In CT, low-density periportal zones are demonstrated as 
periportal thickening when compared with echogenic layers in ultrasound images. These low-intensity 
zones extend uniformly throughout the liver lobes and are enhanced after an intravenous injection of 
contrast agents to become either homogenous with or denser than the surrounding hepatic tissue. 
In MRI, on the other hand, periportal bands are demonstrated as areas of hyperintensity on  
T1-weighted sequences and hyperintensity on T2-weighted sequences after the intravenous injection. 
Studies of acute cases applying MRI demonstrated that regions of periportal fibrosis were hyperintense 
on T2-weighted images in all patients (Figure 10). MRI has been known as a highly responsive 
imaging technique for many diffused liver pathologies. Unlike ultrasound imaging, MRI is not a 
dynamic method and also it is not dependent on the examiner. 
In Japan, ultrasound, CT and MRI techniques and endoscopic examinations with biopsies have been 
used to detect lesions related to schistosmiases japonica [114]. Portal hypertension is detected by CT, 
Ultrsound and gastroscopic examination. The MRI imaging diagnoses were performed on chronic 
lesions and/or sequelae of schistosemiasis and in well-equipped hospitals because of its high cost and 
longer time of examination. 
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Figure 10. MRI: Gamma-Gandy bodies (siderotic nodules) pointed by arrows labelled “i” 
in the spleen of a patient diagnosed with hepatosplenicschistosomiasis. Arrow labelled “ii” 
shows the portal vein. Reproduced with permission [112]. 
5.2. Summary 
The summary of biomedical engineering techniques in schistosomiasis disease is listed in Table 7. 
Table 7. Summary of the biomedical engineering techniques in schistosomiasis disease. 
  
Authors Year Studies Methods Findings/Results 
De Lorenzo  
et al. [110] 
1997 
Measurement of body 
water using BIA in 
schistosomiasis 
patients 
Bioelectric Impedance 
Analysis (BIA) 
Percentage of body water is higher in 
patients with schistosomiasis than in 
controls (62.9% ± 3.6% vs.  
57.4% ± 4.3%, p < 0.0005). 
Lambertucci  
et al. [112] 
Cheung  
et al. [113]  
2008 
 
1996 
Detection of liver and 
spleen abnormalities 
caused by 
shistosomamansoni 
using ultrasound 
Ultrasound imaging 
Symptoms of schistosomiasis  
(such as liver and spleen 
abnormalities, formation of collateral 
vessels in the gastrointestinal tract, 
etc.) can be detected using  
ultrasound imaging 
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Table 7. Cont. 
6. Lymphatic Filariasis 
Lymphatic Filariasis which is also known as elephantiasis, is responsible for more than 40 million 
disfigured and infirm people, and intimidating more than 1.3 billion people in 72 countries [8].  
The disease starts when an infected mosquito bites a human and transmits filarial parasites to the 
human lymphatic vessels. Then, three types of filarial worms develop inside the infected body: 
Wuchereria bancrofti, Brugia malayi and Brugia timori. These worms settle in the lymphatic system 
for 6–8 years. During this incubation period, they produce large numbers of microlariae (larvae) that 
interfere with the immune system. Although infection typically takes place during the childhood 
period, painful disfiguration will occur later in life [8]. 
There are two main approaches for diagnosing lymphatic filariasis: microscopic examination and 
serological tests. The first technique is to examine blood smears under the microscope to detect 
microfilariaes. The blood must be collected at night; since the microfilariaes circulate in blood only at 
night. Although this technique has a low sensitivity, it is still considered as an acceptable alternative 
diagnostic method when antigen testing cannot be done [115]. On the other hand, serological tests are 
based on the fact that filarial infection increases the concentrations of antifilarial IgG and IgE in the 
blood. Thus, one can identify antifilarial immunoglobulin type G and E antibodies (IgG, IgE) or filarial 
antigens using ELISA which leads to a higher sensitivity [115]. 
6.1. Biomedical Engineering Approaches 
Few techniques have been investigated in order to overcome the limitations of lymphatic filariasis 
diagnosis. The following sections show the available technologies of ultrasonography, 
lymphoscintigraphy and immunochromatography. 
6.1.1. Ultrasonography 
Ultrasonography has been used to locate and study the movements of active adult filarial worms of 
Wuchereria bancrofti in the scrotal region in men as a diagnostic tool for lymphatic filariasis; while 
Authors Year Studies Methods Findings/Results 
Lambertucci  
et al. [112] 
2008 
Application of CT and 
MRI in detecting 
schistomiasis 
symptons 
Computerized 
Tomography (CT) and 
Magnetic Resonance 
Imaging (MRI) 
In CT, low-density periportal zones 
can be seen as periportal thickening 
when compared with echogenic 
layers in ultrasound images. 
In MRI, periportal bands can be seen 
as areas of hyperintensity on T1- and 
T2-weighted sequences. 
Ohmae  
et al. [114] 
2003 
Application of 
Ultrasound, CT and 
MRI in detecting 
schistomiasis 
symptons 
Ultrasound, 
Computerized 
Tomography (CT), 
Magnetic Resonance 
Imaging (MRI) 
Portal hypertension can be detected 
by CT and US. MRI imaging is more 
suitable for chronic lesions and/or 
sequelae of schistosemiasis 
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only a few cases of adult filariae are observed by ultrasonography in women. This movement of 
Wuchereria bancrofti is described as “filaria dance”; which is considered a sign of the presence of 
Wuchereria bancrofti worms [116]. 
Dreyer et al. [117] used longitudinal ultrasound examination to investigate the microfilaria dance 
sign in the scrotal lymphatic vessels. They found out that ultrasound is a beneficial tool to evaluate in a 
direct and fast way the usefulness of antifilarial drugs. In another study done by Mand et al. [116], 
they used a portable ultrasound unit, a 7.5 MHz linear transducer and a 3.5 MHz curved array 
transducer to examine different positions in subjects’ bodies; in order to locate worm nests. The 
findings showed that ultrasonography is suitable for diagnosis of Wuchereria bancrofti infection in 
female patients as well as males. 
6.1.2. Lymphoscintigraphy 
Radioisotope imaging (scintigraphy) was demonstrated by Freedman et al. [118] as an effective 
way to evaluate severity of the lymphatic filariasis; however, the primary diagnosis must be done by  
non-imaging laboratory assays. 
6.1.3. Immunochromatography 
Weil et al. [119] described an immunochromatographic filarial antigen test using specific 
monoclonal and polyclonal antibodies. The test is done by adding the serum onto a pink sample pad 
which contains dried polyclonal antifilarial antibodies attached to colloidal gold. Then two drops of a 
wash buffer are added to a separate wash pad. If the serum is infected, the labelled antibody and filarial 
antigen move to the top of the card through a nitrocellulose strip resulting in a visible pink line. This 
technique does not need professional operators; since its easy procedure can be done by individuals 
without much training. Moreover, the results are accessible within only few minutes, making this test a 
potentially fast diagnostic tool for lymphatic filariasis infection. 
6.2. Summary 
The summary of biomedical engineering techniques in lymphatic filariasis disease is listed in Table 8. 
Table 8. Summary of biomedical engineering techniques in lymphatic filariasis disease. 
  
Authors Year Studies Methods Findings/Results 
Dreyer  
et al. [117] 
1995 
Application of longitudinal 
ultrasound in detecting lymphatic 
filariasis infection 
Ultrasonography 
The microfilaria dance sign in the 
scrotal lymphatic vessels can be 
detected using ultrasonography. 
Mand  
et al. [116] 
2004 
Detection of lymphatic filariasis 
infection using a 7.5 MHz linear 
transducer and a 3.5 MHz curved  
array transducer 
Ultrasonography 
Using ultrasonography, infestation of 
Wuchereria bancrofti can be detected 
by examining different positions in both 
male and female subjects’ bodies 
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7. Ebola 
The first recognition of Ebola virus infection occurred in 1976 in Zaire, Africa and the mortality 
rate was 88% [7]. There are four types of Ebola virus including: Zaire, Sudan, Ivory Coast, and 
Reston; the first two being responsible for the majority of hemorrhagic human fever resulting in the 
high mortality rate [120]. Ebola can be confused with other diseases such as malaria, since the most 
frequent symptoms include: fever, weakness, vomiting, diarrhea, sore throat and general aches [121]. 
The formal laboratory diagnostic technique is an ELISA, but this technique is not sensitive enough for all 
different stages of disease and is not easily accessible in countries endemic for Ebola infection [122]. 
7.1. Biomedical Engineering Approaches 
Although, ELISA is the routine test for Ebola, two techniques, RT-PCR (reverse transcriptase 
polymerase chain reaction) and an optical biosensor have led to high sensitivity and specificity. 
Optical Immunosensor 
An optical immunosensor based on the photo immobilization technique to detect the two most 
common types of Ebola virus, Zaire and Sudan was developed by Petrosova et al. [120]. The sensor 
was fabricated by coating the tip of a fiber optic with a 200 nm layer of indium tin oxide (ITO), and 
later with polypyrrole benzophenone. The tip is then irradiated with a 345 nm wavelength light at 
intensity of 80 mW·cm−2 to excite the benzophenone radicals to bind to the Ebola virus antigen. The 
fiber tip then goes through a process similar to a standard ELISA. The detection is then performed via 
chemiluminescence measurements using a photo multiplier tube sensor. The results show that the 
immunosensor is able to detect titers as low as 1:960,000 and 1:1,000,000 respectively for the Zaire 
and Sudan strains. 
7.2. Summary 
The summary of the biomedical engineering technique in Ebola disease is listed in Table 9. 
  
Authors Year Studies Methods Findings/Results 
Freedman  
et al. [118] 
1994 
Application of radioisotope 
imaging (scintigraphy) in detecting 
lymphatic filariasis infection 
Lymphoscintigraphy 
Radioisotope imaging allows the 
evaluation of the severity of the 
lymphatic filariasis infection 
Weil  
et al. [119] 
1997 
Development of an antigen test 
using sample pad containing dried 
polyclonal antifilarial antibodies 
attached to colloidal gold 
Immuno-chromatography 
The sample pad produced a visible 
pink line when infected serum is 
added to it. The technique does not 
need professional and produces 
results within a few minutes.  
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Table 9. Summary of the biomedical engineering technique in Ebola disease. 
Authors Year Studies Methods Findings/Results 
Petrosova  
et al [120] 
2007 
Development of 
immunosensor for 
Zaire and Sudan trains 
using fiber optic 
Optical 
Immunosensor 
The immunesensor is able to  
detect Zaire and Sudan strains in 
titers as low as 1:960,000 and 
1:1,000,000 respectively 
8. Leprosy 
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. The cause of the disease was 
identified in 1873 by G.H.A. Hansen and is also known as Hansen’s disease [123]. It remains a public 
health problem and transmission continues, although prevalence has been reduced in the past half 
century. Never the less leprosy remains as a leading infectious disease causing disabilities. At the 
beginning of 2011, the global registered prevalence of leprosy from 130 territories stood around 
192,000 cases, while during 2010 the number of newly detected cases was about 228,000 [9]. The primary 
external sign of leprosy is skin lesions that if left untreated, can be progressive and cause permanent 
damage to the limbs, eyes, nerves and skin. Thus early diagnosis and treatment is essential [124]. 
Mycobacterium leprae cannot be cultured in the laboratory, hence scientists are using innovative 
techniques to measure the interaction of host cells with Mycobacterium leprae, however there still is 
no primary method for prevention of leprosy nor a means of diagnostic and prognostic testing that is 
practical in routine clinical care [125]. Problems with diagnosis of leprosy are related to its insidious 
nature with sometimes conflicting immunological, clinical and pathological manifestations even 
though there is minimal genetic variation among Mycobacterium leprae isolates worldwide. 
An effective diagnosis method for all stages of the diseases is electroneuromyography (ENMG). 
ENMG is a technique where the muscle nerve under study is stimulated with electric current. The 
effectiveness is demonstrated by the presence of electroneuromyographic alterations among 98% of 
leprosy confirmed patients, especially in the diagnosis of pure neural leprosy [126]. 
8.1. Biomedical Engineering Approaches 
Although highly sensitive and specific diagnostic tests for Mycobacterium leprae have yet to be 
established. Imaging techniques and biosensors, especially those based on employing DNA based 
markers, are considered as strong promising leprosy diagnostic techniques. 
Diagnostic Imaging 
The incidence of bone lesions in leprosy is low, but the radiologic findings of chronic and acute 
osteomyelitis that are similar to lesions of other granulomatous infectious agents are seen. Employing 
imaging techniques various degrees of reabsorption of the body associated with leprosy involving feet 
and hands with loss of disorganizing arthropathies and digits in small joints can be  
visualized [126,127]. 
Magnetic resonance imaging (MRI) and ultrasonography (US) have been used as imaging 
techniques for evaluation of pure neural leprosy. These imaging techniques employ specific markers 
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and they have been used to assist in determining diagnosis and prognosis. US provides high resolution 
images of the morphological alternations in peripheral nerves; however the value of this technique in 
the diagnosis of peripheral neuropathy is poorly understood. Moreover, the application of MRI in 
leprosy peripheral nerve involvement has been described in the literature, and there have been studies 
of leprosy diagnosis using these techniques [127]. Goulart & Goulart [126] have shown that MRI and 
Doppler ultrasonography have a sensitivity of 92% and 74%, respectively, to identify active reversal 
reactions, based on the observation of the color flow signals. However, in case of tender neuropathy, 
MRI may exclude nerve abscess, while US examination can be done more rapid and effective than 
MRI imaging. 
8.2. Summary 
The summary of the biomedical engineering technique in leprosy disease is listed in Table 10. 
Table 10. Summary of the biomedical engineering technique in leprosy disease.  
9. Leishmaniasis 
Leishmaniasis is a neglected parasitic disease that is caused by the protozoan parasite of the 
Leishmania genus and spread by the bite of female phlebotomine sand flies [12,128]. These flies inject 
the infective stage of promastigote parasites into human hosts [10]. These are then phagocytized by 
macrophages and transformed into amastigotes which will develop in the infected cells and cause skin 
lesions that will take months or even years to heal [10] or which if left untreated, may be fatal [128]. 
Leishmaniasis is a public health problem that has being reported to have a 500% increasing incidence 
in the most endemic areas in Africa, Asia, the Middle East, and the Mediterranean [10,11]. 
The established gold standards for Leishmaniasis detection involve the isolation of parasites either 
microscopically or by culture [12]. Existing available diagnostic tests include histology, culture, 
molecular techniques, Leishmanin skin test and serologic skin tests. Never the less those diagnostic 
tests have their own limitations particularly due to false positives with Chagas disease and also to a 
lesser extent to tuberculosis and leprosy [10,12]. 
9.1. Biomedical Engineering Approaches 
To overcome the limitations of current diagnostic techniques, integrated electronic biosensors 
systems that are suitable for field diagnosis are being developed [12]. 
  
Authors Year Studies Methods Findings/Results 
Goulart & 
Goulart [126] 
2008 
Applications of MRI 
and US in detecting 
symptoms of Leprosy 
Magnetic 
resonance imaging 
(MRI) and 
ultrasonography 
MRI and ultrasonography have a sensitivity 
of 92% and 74% respectively in identifying 
active reversal reactions. Ultrasonography 
examinations can be done more rapidly and 
effectively than MRI imaging. 
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Impedance-Based Biosensor 
Perinoto et al. [12] developed a nanostructured biosensor system to detect specific anti-leishmania 
antibodies by measuring the capacitance of proteoliposomes integrated onto gold interdigitated 
electrodes. These electrodes were functionalized by attaching antigenic proteins to the surface through 
repeated immersing of the electrodes into a solution containing the antigenic proteins. Electrical 
capacitance measurements of this structure containing immobilized proteoliposomes allow the 
recognition of specific anti-Leishmania amazonensis antibodies at the concentration of 10−5 mg/mL [12]. 
This technique can be applied for the diagnosis of other protozoan and bacterial infectious diseases 
such as the tuberculosis, malaria, filariasis, schistosomiasis, onchocerciasis and other neglected diseases. 
9.2. Summary 
The summary of the biomedical engineering technique in Leishmaniasis disease is listed in Table 11. 
Table 11. Summary of the biomedical engineering technique in Leishmaniasis disease. 
10. American Trypanosomiasis (Chagas Disease) 
American trypanosomiasis, or Chagas disease is endemic in tropical areas and is caused by the 
parasite Trypanosome cruzi. The parasite is transmitted by the triatomine family of bugs (commonly 
known as “kissing bugs”) that act as reservoirs and vectors in endemic areas. As of 2002, 5–6 million 
people were infected worldwide, with 25 million more at risk [129]. The Disease is typically found in 
Latin America, however, due to population mobility, the disease has been increasingly detected in 
North America, Europe and Western Pacific countries [129]. 
There are two phases of the disease: acute and chronic. The acute phase starts when the parasite 
Trypanosome cruzi enters the body, and may last from 4 to 8 weeks. Local reaction at the point of 
entry such as skin irritation occurs due to the bug bite or entry through the conjunctiva. Once 
Trypanosome cruzi enters the body, the patient may experience common symptoms such as fever, 
vomiting, diarrhoea, and anorexia. During this phase, a patient experiences acute myocarditis, where 
an ECG may show signs of sinus tachycardia, first degree atrio-ventricular (A-V) block, low QRS 
voltage, or primary T-wave changes. The chronic phase starts when the parasite can no longer be 
detected in the blood, and symptoms of myocarditis and meningoencephalitis disappear. In this phase, 
detection can only be done through serological tests such as IgG antibody detection. In the chronic 
phase, 10%–30% of patients may suffer cardiac damage, while others may experience damage to the 
cardiac conduction network and the autonomic nervous system [129,130]. 
For diagnosis of the acute phase of infection, parasites can be detected by direct parasitological 
tests. Thin and thick blood smears allow microscopic observation of the parasite. [129,130]. In the 
Authors Year Studies Methods Findings/Results 
Perinoto  
et al. [12] 
2010 
Development of 
nanostructured biosensor 
system by integrating 
proteoliposomes onto gold 
interdigitated electrodes. 
Impedance-based 
biosensor 
Measuring the electrical capacitance of the 
biosensor allow the recognition of specific 
anti-Leishmania amazonensis antibodies 
at concentration of 10−5 mg/mL 
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chronic phase, only 50% of the patients may show positive results using parasitological tests. 
Serological tests such as haemagglutination, indirect immuno fluorescence, and ELISA are more 
applicable. Current approaches of detection have limitations in terms of consistency of results, and 
requiring at least two techniques to be positive in order to properly diagnose Chagas infection. 
However, as untreated Chagas may lead to damage to the cardiac conduction and autonomic nervous 
system, biomedical engineering approaches have been investigated and developed for a more accurate 
diagnosis of the disease.  
10.1. Biomedical Engineering Approaches 
In order to overcome the difficulties faced in Chagas diagnosis, biomedical engineers have 
developed more accurate tools to help diagnose and identify the disease. This instrumentation consists 
of biosensors that are based on electric impedance and current measurements. 
Biosensors 
A Chagas disease biosensor has been reported by Diniz et al. [131]. It had gold and platinum 
electrodes that were coated with an oxide layer and recombinant antigens (cytoplasmic repetitive 
antigen and flagellar repetitive antigen for Chagas), and dipped in patient’s serum. The study showed 
that complex impedance increases much faster when the electrodes are dipped in Chagas positive 
serum, compared to a slower increase in impedance when dipped in Chagas negative serum.  
In a similar study by Ribone et al. [132], a biosensor utilizing gold electrodes was constructed. 
Similar to the Chagas ELISA method, the electrode is covered with Trypanosome cruzi antigen that 
reacts with patients’ anti-Trypanosome cruzi IgG. A classic enzyme label using horseradish peroxidase 
conjugated with anti-human IgG was applied. However, instead of using the typical optical detection 
method, a potential of less than 0.1 V was applied and electrode current was measured. An increase in 
current indicates an increase in IgG antibody. In a separate study by Belluzo et al. [133], the same 
biosensor was improvised with custom made chimeric receptors that react with the IgG antibody. The 
biosensor was shown to achieve 100% specificity while attaining increased sensitivity with a detection 
limit that is eight times lower compared to commercially available ELISA kits. 
10.2. Summary 
The summary of biomedical engineering techniques in Chagas disease is listed in Table 12. 
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Table 12. Summary of biomedical engineering techniques in Chagas disease. 
11. Conclusions and Outlook 
This paper has reviewed the biomedical engineering approaches for diagnosing and monitoring 
tropical diseases. Methods such as ultrasound, echocardiography and electrocardiography, strain gauge 
plethysmography, laser Doppler and bioelectrical impedance and other techniques allow a noninvasive 
approach to tropical disease diagnosis and management while overcoming the limitations of 
conventional approaches. Clinical decision support systems based on self-organizing maps, multilayer 
feed-forward neural networks and adaptive neuro-fuzzy inference systems assist clinicians to obtain a 
more specific diagnosis of the disease type and stage, whereas lab-on-chip and micro/nanofluidics and 
photonic approaches allow for a more sensitive and specific diagnosis at lower cost and a shorter 
turnaround time. Although there has been much progress, there are still many opportunities to improve 
these current biomedical engineering approaches as well as to develop new approaches for the 
described and other tropical diseases. 
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